tradingkey.logo
tradingkey.logo
Search

KalVista Pharmaceuticals Announces FDA Approval of EKTERLY

ReutersJul 7, 2025 10:49 AM
facebooktwitterlinkedin

- Kalvista Pharmaceuticals Inc KALV.O:

  • KALVISTA PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF EKTERLY® (SEBETRALSTAT), FIRST AND ONLY ORAL ON-DEMAND TREATMENT FOR HEREDITARY ANGIOEDEMA

  • KALVISTA PHARMACEUTICALS INC - LAUNCHES EKTERLY IN U.S., PRESCRIPTIONS AVAILABLE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI